Glycomics/Glycobiology Market

Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021

Report Code: BT 2776 Jan, 2017, by marketsandmarkets.com

[158 Pages Report] The global glycobiology market is expected to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%. Glycomics is the study of carbohydrates and carbohydrate-containing biomolecules in biological processes. This study is used in diagnostics, drug discovery research, immunology, oncology, and various other applications. Glycomics products are widely used for analysis of cell surface markers, which can act as diagnostic or therapeutic targets. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.

Market Dynamics

Drivers

  • Increasing funding for proteomics & glycomics research and growing R&D expenditure
  • Growth of the proteomics market
  • Technological advancements in glycomics instrumentation

Restraints

  • High degree of consolidation acts as an entry barrier for new entrants
  • Stringent regulatory frameworks and time-consuming approval processes

Opportunities

  • Increased use of personalized medicine
  • Biomarkers identification
  • Developing countries and emerging markets

Challenges

  • High cost of tools and instruments and their maintenance

Increasing funding for proteomics & glycomics research and growing R&D expenditure drives the global glycomics market

The growing demand for remedial treatments for life-threatening diseases, such as cancer, has driven the pace of pharmaceutical and biotechnological R&D as well as overall investments made in this sector. Both glycomics (being the study of glycans) and proteomics (being the study of proteins, and holding a prominent place in glycome R&D) are research-driven sectors. Moreover, glycomic biomarkers are finding significant applications in drug development and diagnostics for such diseases. As a result, the growing availability of funding for these two sectors is expected to aid the growth of the glycomics market, in the coming years.

The following are the major objectives of the study.

  • To define, describe, and forecast the global glycomics market on the basis of product, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze the micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and to provide details of the competitive landscape for market leaders
  • To forecast the market size of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World
  • To strategically profile the key players and comprehensively analyze their market shares and core competencies2
  • To track and analyze the competitive developments such as new product launches, agreements, collaborations, acquisitions, expansion and agreements in the glycomics market

During this research study, major players operating in the glycomics market in various regions have been identified, and their offerings, regional presence, and distribution channels have been analyzed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Factiva, along with primary respondents. The entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) pertaining to the market. The figure below shows the breakdown of the primaries on the basis of the company type, designation, and region considered during the research study.

Glycobiology / Glycomics Market

To know about the assumptions considered for the study, download the pdf brochure

Major players in the glycobiology market are Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).

Major Market Developments

  • In November 2016, ProZyme Inc. (U.S.) launched the Gly-Q glycan analysis system, an integrated platform for high-throughput, user-friendly glycoanalysis. With this system, biopharma companies can determine the glycan profiles of their samples faster, while reducing overall costs. It will benefit researchers running glycomic analysis of large datasets, including clinical samples.
  • In December 2015, Waters Corporation (U.S.) announced the launch of the GlycoWorks RapiFluor-MS N-Glycan kit in a 24-sample format. The new format processes 24 samples, 8 at a time. It helps laboratories transform their monoclonal antibody glycoprofiling methodology
  • In November 2015, Merck KGaA (Germany) acquired Sigma-Aldrich (US) for an approximate value of USD 17 billion. This acquisition helped the company expand its business in various geographies and enhanced its product portfolio, including life science and diagnostic.
  • In February 2014, Thermo Fisher Scientific acquired Life Technologies for an approximate value of USD 13.6 billion, plus the assumption of USD 1.5 billion in net debt. This acquisition helped the company expand its business in various geographies and enhanced its product portfolio

Target Audience for this Report:

  • Glycomics enzymes, kits, reagents, and instruments manufacturers and vendors
  • Associations related to glycomics enzymes, kits, and reagents
  • Research institutes and contract research organizations (CROs)
  • Market research and consulting firms
  • Life sciences instrumentation and reagent companies
  • Pharmaceutical and biotechnology companies
  • Clinical research institutes

Scope of the Report:<

This report categorizes the glycobiology market into the following segments:

Glycobiology Market, by Product

  • Enzymes
    • Glycosidases
    • Glycosyltransferases
    • Neuraminidases
    • Sialyltransferases
    • Other Enzymes
  • Instruments
    • Antibody Arrays
    • HPLC
    • Lectin Arrays
    • MALDI-TOF
    • Mass Spectrometers
    • Other Glycomics Instruments
  • Kits
    • Glycan Labeling Kits
    • Glycan Purification Kits
    • Glycan Release Kits
    • Other Kits
  • Reagents
    • Glycoproteins
    • Monosaccharides
    • Oligosaccharides
    • Other Reagents

Glycobiology Market, by Application

  • Diagnostics
  • Drug Discovery & Development
  • Oncology
  • Immunology
  • Other Applications

Glycobiology Market, by End User

  • Academic Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations

Glycobiology Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • RoE
  • Asia
    • Japan
    • China
    • India
    • Rest of Asia (RoA)
  • Rest of the World (RoW)
    • South America
    • Middle East and Africa
    • Pacific and Oceania

Critical questions which the report answers

  • What are new application areas which the glycomics companies are exploring?
  • Which are the key players in the market and how intense is the competition?

Available Customizations:

  • Company Information: Detailed company profiles of five or more market players
  • Opportunity Assessment: A detailed report underlining the various growth opportunities presented in the market

The global glycobiology market is poised to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%. Glycomics products are widely used for the analysis of cell surface markers, which can act as diagnostic or therapeutic targets. Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of the market.

Glycomics is a promising approach to biomarker discovery and validation. The development of various separation techniques coupled with the advanced structure determination capabilities of this field makes possible the separation and identification of thousands of glycans from complex mixtures. Biomarker identification presents significant opportunities for the glycomics market. Glycomics also has a wide range of applications in drug development and enhancement. Glycomics products such as enzymes, kits, and reagents are often used in investigating the role of sugars in the development and progression of diseases like cancer, Alzheimer’s, Parkinson’s, and various infectious diseases like herpes and AIDS.

On the basis of product, the market is segmented into enzymes, instruments, kits, and reagents. The enzymes segment is projected to grow at the highest CAGR during the forecast period. This growth is mainly attributed to their consumable nature and wide applications in a variety of R&D and drug discovery procedures. The enzymes segment is further divided into glycosidases, glycosyltransferases, neuraminidases, sialyltransferases, and other enzymes.

On the basis of region, the market is segmented into North America, Asia, Europe, and RoW. The Asian market is estimated to grow at the highest CAGR during the forecast period. This growth is mainly attributed to the increasing commercialization of R&D by pharmaceutical and biotechnology companies, growing demand for personalized medicine, and rising importance of companion diagnostics. Over the past few years, the overall Asian region has witnessed growth in the glycomics market as North American and European pharmaceutical drug manufacturers find it cost-effective to outsource their glycomics-based work to Asian manufacturers or set up their manufacturing facilities in Asian countries.

Glycobiology / Glycomics Market

Glycomics/Glycobiology applications in drug discovery and development and oncology drive the growth of glycobiology market

Drug discovery and development

Glycomics is an important tool for analyzing target drugs and developing relevant therapeutic leads, which helps in accelerating drug development. One of the most crucial bottlenecks of the drug discovery process includes the development of the right drug for the right target. More than 90% of druggable targets belong to the class of proteins. Glycomics research is associated with proteomic processes to cater to the needs of the pharmaceutical industry for the identification of new targets to gain insights into drug actions. Glycomics also aids in the investigation of defective proteins and how they may cause particular diseases, which by extension helps in developing new drugs. The use of glycomics has increased significantly as it enables biomarker analysis, carbohydrate synthesis, glycoengineering, as well as drug and vaccine discovery and development.

Oncology

Glycomics plays a crucial role in analyzing the molecular mechanism of various types of cancers. Glycomics also plays an important role in identifying new biomarkers for cancers. Biomarkers are used as key diagnostic targets for various types of cancers. They can also be used for devising novel and personalized therapies for cancer patients. Owing to its ability to differentiate between protein sub-types based on the molecular structure of their glycan patterns, glycomics has emerged as an important research tool for the discovery and validation of protein-based cancer biomarkers.

Critical questions the report answers:

  • Where will all these developments take the industry in the mid to long term?
  • What are the upcoming industry applications for glycomics/glycobiology?

There is a high degree of rivalry amongst market players, which keeps the market highly competitive. The top players in glycomics market are large and well-established players, who enjoy strong brand loyalty. New entrants in this market have to compete with existing players and differentiate themselves and their product offerings; this will require high capital, R&D, and manufacturing investments. Additionally, R&D in this market is a very time-consuming process and needs heavy investments in terms of human efforts and time as well. These factors are restraining the entry of new players, and as such are expected to restrain the growth potential of this market.

The key players in the glycobiology market include Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 13)
    1.1 Objectives of the Study
    1.2 Markets Definition
    1.3 Markets Covered
           1.3.1 Years Considered for the Study
    1.4 Currency
    1.5 Market Scope
    1.6 Market Stakeholders

2 Research Methodology (Page No. - 16)
    2.1 Glycomics Market Size Estimation
    2.2 Glycomics Market Breakdown and Data Triangulation
    2.3 Glycomics Market Share Estimation
           2.3.1 Key Data From Secondary Sources
           2.3.2 Key Data From Primary Sources
           2.3.3 Assumptions for the Study

3 Executive Summary (Page No. - 23)

4 Premium Insights (Page No. - 28)
    4.1 Glycomics: Market Overview (2016-2021)
    4.2 Geographic Analysis: Glycomics Market, By Product
    4.3 Life Cycle Analysis, By Region

5 Market Overview (Page No. - 31)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                     5.2.1.1 Increase in Funding for Proteomics and Glycomics Research, Growing R&D Expenditure
                     5.2.1.1 Growth of the Proteomics Market
                     5.2.1.2 Technological Advancements in Glycomics Instrumentation
           5.2.2 Restraints
                     5.2.2.1 High Degree of Consolidation Hinders Entry of New Players to the Market
                     5.2.2.2 Stringent Regulatory Frameworks and Time-Consuming Approval Processes
           5.2.3 Opportunities
                     5.2.3.1 Increased Use of Personalized Medicine
                     5.2.3.2 Biomarker Identification
                     5.2.3.3 Developing Countries and Emerging Markets
           5.2.4 Challenges
                     5.2.4.1 High Costs of Tools & Instruments and Their Maintenance

6 Glycomics Market, By Product (Page No. - 37)
    6.1 Introduction
    6.2 Enzymes
           6.2.1 Glycosidases
           6.2.2 Glycosyltransferases
           6.2.3 Neuraminidases
           6.2.4 Sialyltransferases
           6.2.5 Other Glycomics Enzymes
    6.3 Instruments
           6.3.1 Antibody Arrays
           6.3.2 HPLC
           6.3.3 Lectin Arrays
           6.3.4 MALDI-TOF
           6.3.5 Mass Spectrometers
           6.3.6 Other Glycomics Instruments
    6.4 Kits
           6.4.1 Glycan Labeling Kits
           6.4.2 Glycan Purification Kits
           6.4.3 Glycan Release Kits
           6.4.4 Other Glycomics Kits
    6.5 Reagents
           6.5.1 Glycoproteins
           6.5.2 Monosaccharides
           6.5.3 Oligosaccharides
           6.5.4 Other Reagents

7 Glycobiology Market, By Application (Page No. - 58)
    7.1 Introduction
    7.2 Diagnostics
    7.3 Drug Discovery & Development
    7.4 Oncology
    7.5 Immunology
    7.6 Other Applications

8 Glycobiology Market, By End User (Page No. - 67)
    8.1 Introduction
    8.2 Academic Research Institutes
    8.3 Pharmaceutical & Biotechnology Companies
    8.4 Contract Research Organizations

9 Glycobiology Market, By Region (Page No. - 73)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 France
           9.3.3 U.K.
           9.3.4 Italy
           9.3.5 Spain
           9.3.6 RoE
    9.4 Asia
           9.4.1 China
           9.4.2 Japan
           9.4.3 India
           9.4.4 Rest of Asia
    9.5 Rest of the World (RoW)
           9.5.1 South America
           9.5.2 Middle East and Africa
           9.5.3 Pacific and Oceania

10 Competitive Landscape (Page No. - 109)
     10.1 Overview
     10.2 Market Share Analysis
               10.2.1 Glycomics Enzymes, Kits, and Regents
               10.2.2 Glycomics Instruments
     10.3 Competitive Situation and Trends
               10.3.1 Product Launches
               10.3.2 Expansions
               10.3.3 Agreements
               10.3.4 Acquisitions, Collaborations, Approvals, and Others

11 Company Profiles (Page No. - 118)
(Overview, Products and Services, Financials, Strategy & Development)*
     11.1 Introduction
     11.2 Merck KGaA
     11.3 Takara Bio, Inc.
     11.4 Shimadzu Corporation
     11.5 Bruker Corporation
     11.6 Waters Corporation
     11.7 New England Biolabs Inc.
     11.8 Agilent Technologies, Inc.
     11.9 Danaher Corporation
     11.10 ProZyme, Inc.
     11.11 Thermo Fisher Scientific, Inc.

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 149)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Introducing RT: Real Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Reports
     12.7 Author Details


List of Tables (91 Tables)

Table 1 Glycobiology Market Summary
Table 2 Glycobiology Market Size, By Product, 2014–2021 (USD Million)
Table 3 Glycomics Enzymes Market Size, By Product, 2014–2021 (USD Million)
Table 4 Glycomics Enzymes Market Size, By Region, 2014-2021 (USD Million)
Table 5 Glycosidases Market Size, By Region, 2014-2021 (USD Million)
Table 6 Glycosyltransferases Market Size, By Region, 2014-2021 (USD Million)
Table 7 Neuraminidases Market Size, By Region, 2014-2021 (USD Million)
Table 8 Sialyltransferases Market Size, By Region, 2014–2021 (USD Million)
Table 9 Other Glycomics Enzymes Market Size, By Region, 2014–2021 (USD Million)
Table 10 Glycomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 11 Glycomics Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 12 Antibody Arrays Market Size, By Region, 2014–2021 (USD Million)
Table 13 HPLC Market Size, By Region, 2014–2021 (USD Million)
Table 14 Lectin Arrays Market Size, By Region, 2014–2021 (USD Million)
Table 15 MALDI-TOF Market Size, By Region, 2014–2021 (USD Million)
Table 16 Mass Spectrometry Market Size, By Region, 2014–2021 (USD Million)
Table 17 Other Glycomics Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 18 Glycomics Kits Market Size, By Type, 2014-2021 (USD Million)
Table 19 Glycomics Kits Market Size, By Region, 2014-2021 (USD Million)
Table 20 Glycan Labeling Kits Market Size, By Region, 2014–2021 (USD Million)
Table 21 Glycan Purification Kits Market Size, By Region, 2014–2021 (USD Million)
Table 22 Glycan Release Kits Market Size, By Region, 2014–2021 (USD Million)
Table 23 Other Glycobiology Kits Market Size, By Region, 2014-2021 (USD Million)
Table 24 Glycobiology Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 25 Glycobiology Reagents Market Size, By Region, 2014-2021 (USD Million)
Table 26 Glycoproteins Market Size, By Region, 2014–2021 (USD Million)
Table 27 Monosaccharides Market Size, By Region, 2014–2021 (USD Million)
Table 28 Oligosaccharides Market Size, By Region, 2014–2021 (USD Million)
Table 29 Other Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 30 Glycobiology Market Size, By Application, 2014–2021 (USD Million)
Table 31 Glycobiology Market Size for Diagnostics, By Region, 2014–2021 (USD Million)
Table 32 Glycobiology Market Size for Drug Discovery and Development, By Region, 2014–2021 (USD Million)
Table 33 Glycobiology Market Size for Oncology, By Region, 2014–2021 (USD Million)
Table 34 Glycobiology Market Size for Immunology, By Region, 2014–2021 (USD Million)
Table 35 Glycobiology Market Size for Other Applications, By Region, 2014–2021 (USD Million)
Table 36 Glycobiology Market Size, By End User, 2014–2021 (USD Million)
Table 37 Glycobiology Market Size for Academic Research Institutes, By Region, 2014–2021 (USD Million)
Table 38 Glycobiology Market Size for Pharmaceutical & Biotechnology Companies, By Region, 2014–2021 (USD Million)
Table 39 Glycobiology Market Size for Contract Research Organizations, By Region, 2014–2021 (USD Million)
Table 40 Glycobiology Market Size, By Region, 2014–2021 (USD Million)
Table 41 North America: Glycobiology Market Size, By Country, 2014–2021 (USD Million)
Table 42 North America: Glycobiology Market Size, By End User, 2014–2021 (USD Million)
Table 43 North America: Glycobiology Market Size, By Product, 2014–2021 (USD Million)
Table 44 North America: Glycomics Enzymes Market Size, By Type, 2014–2021 (USD Million)
Table 45 North America: Glycomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 46 North America: Glycobiology Kits Market Size, By Type, 2014–2021 (USD Million)
Table 47 North America: Glycobiology Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 48 North America: Glycobiology Market Size, By Application, 2014–2021 (USD Million)
Table 49 U.S.: Glycobiology Market Size, By Product, 2014–2021 (USD Million)
Table 50 Canada: Glycobiology Market Size, By Product, 2014–2021 (USD Million)
Table 51 Europe: Glycobiology Market Size, By Country, 2014–2021 (USD Million)
Table 52 Europe: Glycobiology Market Size, By End User, 2014–2021 (USD Million)
Table 53 Europe: Glycobiology Market Size, By Product, 2014–2021 (USD Million)
Table 54 Europe: Glycomics Enzymes Market Size, By Type, 2014–2021 (USD Million)
Table 55 Europe: Glycobiology Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 56 Europe: Glycobiology Kits Market Size, By Type, 2014–2021 (USD Million)
Table 57 Europe: Glycobiology Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 58 Europe: Glycobiology Market Size, By Application, 2014–2021 (USD Million)
Table 59 Germany: Glycobiology Market Size, By Product, 2014–2021 (USD Million)
Table 60 France: Glycobiology Market Size, By Product, 2014–2021 (USD Million)
Table 61 U.K.: Glycobiology Market Size, By Product, 2014–2021 (USD Million)
Table 62 Italy: Glycobiology Market Size, By Product, 2014–2021 (USD Million)
Table 63 Spain: Glycobiology Market Size, By Product, 2014–2021 (USD Million)
Table 64 RoE: Glycobiology Market Size, By Product, 2014–2021 (USD Million)
Table 65 Asia: Glycobiology Market Size, By Country, 2014–2021 (USD Million)
Table 66 Asia: Glycobiology Market Size, By End User, 2014–2021 (USD Million)
Table 67 Asia: Glycobiology Market Size, By Product, 2014–2021 (USD Million)
Table 68 Asia: Glycomics Enzymes Market Size, By Type, 2014–2021 (USD Million)
Table 69 Asia: Glycomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 70 Asia: Glycomics Kits Market Size, By Type, 2014–2021 (USD Million)
Table 71 Asia: Glycomics Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 72 Asia: Glycomics Market Size, By Application, 2014–2021 (USD Million)
Table 73 China: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 74 Japan: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 75 India: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 76 Roa: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 77 RoW: Glycomics Market Size, By Region, 2014–2021 (USD Million)
Table 78 RoW: Glycomics Market Size, By End User, 2014–2021 (USD Million)
Table 79 RoW: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 80 RoW: Glycomics Enzymes Market Size, By Type, 2014–2021 (USD Million)
Table 81 RoW: Glycomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 82 RoW: Glycomics Kits Market Size, By Type, 2014–2021 (USD Million)
Table 83 RoW: Glycomics Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 84 RoW: Glycobiology Market Size, By Application, 2014–2021 (USD Million)
Table 85 South America: Glycobiology Market Size, By Product, 2014–2021 (USD Million)
Table 86 Middle East and Africa: Glycobiology Market Size, By Product, 2014–2021 (USD Million)
Table 87 Pacific and Oceania: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 88 Product Launches, 2013–2016
Table 89 Expansions, 2013-2016
Table 90 Agreements, 2013–2016
Table 91 Acquisitions, Collaborations, Approvals, and Others, 2013–2016
 
 
List of Figures (32 Figures)
 
Figure 1 Global Glycomics Market
Figure 2 Research Methodology
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Break Down of Primary Interviews: By Company Type, Designation, & Region
Figure 6 Data Triangulation Methodology
Figure 7 Enzymes to Register the Highest CAGR Between 2016 & 2021
Figure 8 Glycosidases to Dominate the Glycomics Enzymes Market in 2016
Figure 9 Mass Spectrometry to Grow at the Highest Rate During the Forecast Period
Figure 10 Glycan Release Kits to Dominate the Glycomics Kits Market in 2016
Figure 11 Oligosaccharides to Command the Largest Share of the Glycomics Reagents Market in 2016
Figure 12 Increasing Funding in Glycomics and Proteomics Research to Drive the North American Glycomics Market
Figure 13 Increasing Funding for Proteomics & Glycomics Research is an Important Growth Driver for the Glycomics Market
Figure 14 Enzymes to Account for the Largest Product Segment of the Glycomics Market in 2016
Figure 15 Asia to Register the Highest CAGR During the Forecast Period
Figure 16 Asia Holds Lucrative Growth Opportunities for Glycomics Products During the Forecast Period
Figure 17 Increasing Government and Private Funding for Proteomics and Glycobiology Research to Drive the Demand for Glycobiology Products
Figure 18 Glycomics Market in Asia to Register Highest Growth During the Forecast
Figure 19 North America: Glycomics Market Snapshot
Figure 20 Asia: Glycomics Market Snapshot
Figure 21 Key Developments in the Global Glycomics Market, 2013–2016
Figure 22 Global Glycomics Enzymes, Kits, and Reagents Market Share Analysis, By Key Player, 2015
Figure 23 Battle for Market Share: Product Launches is the Key Strategy Adopted By Players in the Glycomics Market Between 2013 & 2016
Figure 24 Geographic Revenue Mix of Top 5 Market Players
Figure 25 Merck KGaA: Company Snapshot (2015)
Figure 26 Takara Bio, Inc.: Company Snapshot (2015)
Figure 27 Shimadzu Corporation: Company Snapshot (2015)
Figure 28 Bruker Corporation: Company Snapshot (2015)
Figure 29 Waters Corporation: Company Snapshot (2015)
Figure 30 Agilent Technologies, Inc.: Company Snapshot (2015)
Figure 31 Danaher Corporation Company Snapshot (2015)
Figure 32 Thermo Fisher Scientific, Inc.: Company Snapshot (2015)


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
BT 2776
Published ON
Jan, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Glycomics/Glycobiology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved